Health Care

Health insurance company Aetna (NYSE:AET) will completely exit the ObamaCare exchanges in 2018.

Wall Street firm Cantor Fitzgerald finds itself in a sticky political situation.

AllergyKids Foundation Founder Robyn O’Brien on Wednesday weighed in on Mylan Chairman Robert Coury and why there may be a “monopoly” on EpiPens.

Jonathan Gruber, a well-known architect of President Obama’s Affordable Care Act, pushed back against claims ObamaCare has failed.

EpiPen maker Mylan said first-quarter profit more than quadrupled, as the maker of generic drugs benefited from strong demand outside the United States.

House Speaker Paul Ryan is turning his attention to tax reform Wednesday following the House of Representatives’ vote to advance the GOP heath care bill last week.

Tractor-trailers with side guard rails mounted between their tires are less likely to be involved in fatal crashes, an auto safety group says.

Senate Democrats are asking Republican leaders to drop their effort to repeal President Barack Obama's health care law.

Almost one-third of new drugs approved by U.S. regulators over a decade ended up later with warnings about sometimes serious side effects.

French drugmaker Sanofi has pledged to peg U.S. drug price rises to below healthcare inflation in a move that limits increases for any product this year to 5.4 percent, unless there are exceptional circumstances.

Valeant Pharmaceuticals International Inc. is reporting first-quarter net income of $628 million, after reporting a loss in the same period a year earlier.

The man who successfully mapped the human genome is hoping to figure out how to cheat death with a new test.

The Republican Party will be rewarded for doing "what's right" by voting to overhaul a "failing and collapsing" health care system.

Berkshire Hathaway Vice Chairman Charlie Munger on Monday discussed why it’s wrong for hospitals to give chemotherapy to people that are too sick to recover.